APOL1 Genotyping CTA Clinical Performance Study

Clinical trial NCT06839833 · RECRUITING

Trial details

NCT number: NCT06839833
Sponsor: Almac Diagnostic Services LLC
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

APOL1-mediated Kidney Disease

Start date: 2025-03-06
Primary completion: 2027-02-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.